Unity Biotechnology (NASDAQ:UBX) Shares Down 26.5% – What’s Next?
Unity Biotechnology, Inc. (NASDAQ:UBX – Get Free Report) was down 26.5% during trading on Wednesday . The stock traded as low as $1.24 and last traded at $1.33. Approximately 457,354 shares were ...
UNITY Biotechnology Reports Granting of New Employment Inducement Award
NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that on January 6, 2025, the Compensation Committee of the Board of Directors ...
UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer
UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse ...
Unity Biotechnology Names Federico Grossi Chief Medical Officer, Pre-market Stock Rises
Shares of Unity Biotechnology, Inc. (UBX) are gaining 9% in the pre-market trading after it has announced the appointment of Federico ...
CNN4y
Unity Biotechnology, Inc.
Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic ...
We're Keeping An Eye On Unity Biotechnology's (NASDAQ:UBX) Cash Burn Rate
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...
Nasdaq18d
Unity Biotechnology, Inc. Common Stock (UBX) Analyst Research
This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets ...
Wall Street Journal6mon
Unity Biotechnology Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...